发明名称 Enantioselective preparation of quinoline derivatives
摘要 Disclosed is a process for preparing 8-substituted oxy-5-((R)-2-halo-1-hydroxy-ethyl)-(1H)-quinolin-2-ones or acceptable solvates thereof comprising reacting a 5-(alpha-haloacetyl)-8-substituted oxy-(1H)quinolin-2-one with a reducing agent in the presence of a chiral agent and a base to form a 8(substituted oxy)-5-((R)-2-halo-l-hydroxy-ethyl)-(1H)-quinolin-2-one, said chiral agent having a formula I or II wherein: M is Ru, Rh, Ir, Fe, Co or Ni; L is aryl or an aryl-aliphatic residue, in either case being optionally linked to a polymer; X is hydrogen or halo; R1 is an aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, aryl, aryl-aliphatic residue or a 4- to 12-membered heterocyclic group, which, in each case, is optionally linked to a polymer; and R2 and R3 are phenyl, or R2and R3 together with the carbon atom to which they are attached form a cyclohexane or cyclopentane ring.
申请公布号 NZ551276(A) 申请公布日期 2010.06.25
申请号 NZ20050551276 申请日期 2005.06.21
申请人 NOVARTIS AG 发明人 LOHSE, OLIVIER;VOGEL, CASPAR;PENN, GERHARD
分类号 C07D215/26;C07D215/00;C07D251/26 主分类号 C07D215/26
代理机构 代理人
主权项
地址